Ignite Creation Date:
2025-12-24 @ 2:34 PM
Ignite Modification Date:
2025-12-27 @ 5:48 AM
Study NCT ID:
NCT04319159
Status:
COMPLETED
Last Update Posted:
2021-11-11
First Post:
2020-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic Keratosis (AK)
Sponsor:
Biofrontera Bioscience GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ALA-AK-CT015
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None